{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:10:57Z","timestamp":1794107457364,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005413","name":"Universit\u00e9 Paris Descartes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022312","name":"Soci\u00e9t\u00e9 Fran\u00e7aise d'H\u00e9matologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jid.2019.07.719","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T01:47:42Z","timestamp":1567216062000},"page":"593-601.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Estrogens Counteract the Profibrotic Effects of TGF-\u03b2 and their Inhibition Exacerbates Experimental Dermal Fibrosis"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2463-218X","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Avouac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-7229","authenticated-orcid":false,"given":"Sonia","family":"Pezet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-2212","authenticated-orcid":false,"given":"Virginie","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5487-9191","authenticated-orcid":false,"given":"L\u00e9a","family":"Baudoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9973-1847","authenticated-orcid":false,"given":"Anne","family":"Cauvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0549-9192","authenticated-orcid":false,"given":"Barbara","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5891-1868","authenticated-orcid":false,"given":"Gon\u00e7alo","family":"Boleto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0500-5209","authenticated-orcid":false,"given":"Marie Laure","family":"Brandely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4599-3881","authenticated-orcid":false,"given":"Manon","family":"Elmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-0002","authenticated-orcid":false,"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2019.07.719_bib1","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/ar4140","article-title":"Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis","volume":"15","author":"Aida-Yasuoka","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2019.07.719_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/annrheumdis-2012-201759","article-title":"Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis","volume":"72","author":"Avouac","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2019.07.719_bib3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.30171","article-title":"Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis","volume":"63","author":"Avouac","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2019.07.719_bib4","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/art.33501","article-title":"Inhibition of activator protein 1 signaling abrogates transforming growth factor \u03b2-mediated activation of fibroblasts and prevents experimental fibrosis","volume":"64","author":"Avouac","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2019.07.719_bib5","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/art.38819","article-title":"The nuclear receptor constitutive androstane receptor\/NR1I3 enhances the profibrotic effects of transforming growth factor \u03b2 and contributes to the development of experimental dermal fibrosis","volume":"66","author":"Avouac","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2019.07.719_bib6","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/art.27647","article-title":"Animal models of systemic sclerosis: prospects and limitations","volume":"62","author":"Beyer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2019.07.719_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.2011010046","article-title":"Antifibrotic effect of tamoxifen in a model of progressive renal disease","volume":"23","author":"Dell\u00ea","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jid.2019.07.719_bib8","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1186\/ar4672","article-title":"Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis","volume":"16","author":"Desallais","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2019.07.719_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/annrheumdis-2014-206386","article-title":"A\u00a0gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study","volume":"75","author":"Elhai","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2019.07.719_bib10","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2019.07.719_bib11","first-page":"69","article-title":"The mighty fibroblast and its utility in scleroderma research","volume":"2","author":"Garrett","year":"2017","journal-title":"J\u00a0Scleroderma Relat Disord"},{"key":"10.1016\/j.jid.2019.07.719_bib12","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1349-7006.2011.01977.x","article-title":"Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-\u03b2 signaling pathway","volume":"102","author":"Goto","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jid.2019.07.719_bib13","doi-asserted-by":"crossref","first-page":"14747","DOI":"10.1074\/jbc.M109.093039","article-title":"Estrogen inhibits transforming growth factor beta signaling by promoting Smad2\/3 degradation","volume":"285","author":"Ito","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2019.07.719_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00841473","article-title":"[Significance of estradiol in the development of fibrosis in systemic scleroderma (bases of sexual predisposition to the disease)]","volume":"111","author":"Kashnikova","year":"1991","journal-title":"Biull Eksp Biol Med"},{"key":"10.1016\/j.jid.2019.07.719_bib15","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2019.07.719_bib16","doi-asserted-by":"crossref","first-page":"42908","DOI":"10.1074\/jbc.M105316200","article-title":"Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3","volume":"276","author":"Matsuda","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2019.07.719_bib17","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/HYPERTENSIONAHA.111.180976","article-title":"Effects of estrogen on cardiovascular injury in ovariectomized female DahlS.Z-Lepr(fa)\/Lepr(fa) rats as a new animal model of metabolic syndrome","volume":"59","author":"Murase","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jid.2019.07.719_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1196\/annals.1386.021","article-title":"A\u00a0potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"1089","author":"Offner","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jid.2019.07.719_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-62-2-281","article-title":"Studies on the pathogenesis of rheumatoid joint inflammation: II. Intracytoplasmic particulate complexes in rheumatoid synovial fluids","volume":"62","author":"Rawson","year":"1965","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jid.2019.07.719_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archfaci.8.5.329","article-title":"Effects of tamoxifen on normal human dermal fibroblasts","volume":"8","author":"Ruffy","year":"2006","journal-title":"Arch Facial Plast Surg"},{"key":"10.1016\/j.jid.2019.07.719_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13075-015-0659-5","article-title":"Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis","volume":"17","author":"Ruzehaji","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2019.07.719_bib22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1378\/chest.111.4.1137","article-title":"Successful treatment of sclerosing cervicitis and fibrosing mediastinitis with tamoxifen","volume":"111","author":"Savelli","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.jid.2019.07.719_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2009.05296.x","article-title":"Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts","volume":"1193","author":"Soldano","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jid.2019.07.719_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ard.62.4.341","article-title":"Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies","volume":"62","author":"Sthoeger","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2019.07.719_bib25","first-page":"99","article-title":"Open label trial of tamoxifen in scleroderma","volume":"21","author":"Thomas-Golbanov","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2019.07.719_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.vph.2009.06.002","article-title":"2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats","volume":"51","author":"Tofovic","year":"2009","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jid.2019.07.719_bib27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/annrheumdis-2012-203095","article-title":"Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-\u03b2 signalling to prevent fibrosis","volume":"73","author":"Tomcik","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2019.07.719_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2019.07.719_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","article-title":"Transforming growth factor beta as a therapeutic target in systemic sclerosis","volume":"5","author":"Varga","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2019.07.719_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5301\/jsrd.5000249","article-title":"Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities","volume":"2","author":"Varga","year":"2017","journal-title":"J\u00a0Scleroderma Relat Disord"},{"key":"10.1016\/j.jid.2019.07.719_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rdc.2007.11.002","article-title":"Fibrosis in systemic sclerosis","volume":"34","author":"Varga","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jid.2019.07.719_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1165\/rcmb.2007-0340OC","article-title":"Male sex hormones exacerbate lung function impairment after bleomycin-induced pulmonary fibrosis","volume":"39","author":"Voltz","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jid.2019.07.719_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.canlet.2016.08.012","article-title":"G\u00a0protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis","volume":"382","author":"Wei","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jid.2019.07.719_bib34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","article-title":"Sex differences in autoimmune disease","volume":"2","author":"Whitacre","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2019.07.719_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0003-9861(61)90319-8","article-title":"Connective tissue development in subcutaneously implanted polyvinyl sponge. I. Biochemical changes during development","volume":"93","author":"Woessner","year":"1961","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jid.2019.07.719_bib36","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2019.07.719_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MEG.0b013e32835ab5dc","article-title":"Estrogen derivatives: novel therapeutic agents for liver cirrhosis and portal hypertension","volume":"25","author":"Zhang","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jid.2019.07.719_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2014.10.007","article-title":"2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation","volume":"77","author":"Zhu","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2019.07.719_bib39","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1002\/art.30536","article-title":"Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells","volume":"63","author":"Avouac","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2019.07.719_bib40","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/annrheumdis-2012-201759","article-title":"Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis","volume":"72","author":"Avouac","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2019.07.719_bib41","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.30171","article-title":"Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis","volume":"63","author":"Avouac","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2019.07.719_bib42","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/art.33501","article-title":"Inhibition of activator protein 1 signaling abrogates transforming growth factor \u03b2-mediated activation of fibroblasts and prevents experimental fibrosis","volume":"64","author":"Avouac","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2019.07.719_bib43","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/art.38819","article-title":"The nuclear receptor constitutive androstane receptor\/NR1I3 enhances the profibrotic effects of transforming growth factor \u03b2 and contributes to the development of experimental dermal fibrosis","volume":"66","author":"Avouac","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2019.07.719_bib44","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1002\/art.23968","article-title":"Angiogenesis in systemic sclerosis: impaired expression of vascular\u00a0endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions","volume":"58","author":"Avouac","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2019.07.719_bib45","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1186\/ar4672","article-title":"Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis","volume":"16","author":"Desallais","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2019.07.719_bib46","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2019.07.719_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-62-2-281","article-title":"Studies on the pathogenesis of rheumatoid joint inflammation. II. Intracytoplasmic particulate complexes in rheumatoid synovial fluids","volume":"62","author":"Rawson","year":"1965","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jid.2019.07.719_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0003-9861(61)90319-8","article-title":"Connective tissue development in subcutaneously implanted polyvinyl sponge. I. Biochemical changes during development","volume":"93","author":"Woessner","year":"1961","journal-title":"Arch Biochem Biophys"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19332063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19332063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:44:27Z","timestamp":1762206267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X19332063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0022202X19332063"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2019.07.719","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogens Counteract the Profibrotic Effects of TGF-\u03b2 and their Inhibition Exacerbates Experimental Dermal Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2019.07.719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}